Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 8,965 | 10,951 | 5,383 | 0 | 0 |
| Cost of Goods | 550 | 200 | 93 | N/A | N/A |
| Gross Profit | 8,415 | 10,751 | 5,290 | N/A | N/A |
| Operating Expenses | 37,669 | 33,663 | 33,642 | 40,845 | 32,641 |
| Operating Income | -28,704 | -22,712 | -28,259 | -20,095 | -32,641 |
| Other Income | -154 | -225 | 61,672 | 162 | -191 |
| Pre-tax Income | -28,858 | -22,937 | 33,413 | -19,933 | -32,832 |
| Net Income Continuous | -28,858 | -22,937 | 33,413 | -19,933 | -32,832 |
| Net Income | $-28,858 | $-22,937 | $33,413 | $-19,933 | $-32,832 |
| EPS Basic Total Ops | -0.66 | -0.53 | 0.80 | -0.48 | -0.82 |
| EPS Basic Continuous Ops | -0.66 | -0.53 | 0.80 | -0.49 | -0.82 |
| EPS Diluted Total Ops | -0.66 | -0.53 | 0.75 | -0.48 | -0.82 |
| EPS Diluted Continuous Ops | -0.66 | -0.53 | 0.75 | -0.49 | -0.82 |
| EBITDA(a) | $-28,559 | $-22,496 | $-28,129 | $-40,728 | $-32,548 |